84 related articles for article (PubMed ID: 12883655)
1. Acute intracerebroventricular administration of either carboxyl-terminal or amino-terminal fragments of agouti-related peptide produces a long-term decrease in energy expenditure in rats.
Goto K; Inui A; Takimoto Y; Yuzuriha H; Asakawa A; Kawamura Y; Tsuji H; Takahara Y; Takeyama C; Katsuura G; Kasuga M
Int J Mol Med; 2003 Sep; 12(3):379-83. PubMed ID: 12883655
[TBL] [Abstract][Full Text] [Related]
2. Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3.
Creemers JW; Pritchard LE; Gyte A; Le Rouzic P; Meulemans S; Wardlaw SL; Zhu X; Steiner DF; Davies N; Armstrong D; Lawrence CB; Luckman SM; Schmitz CA; Davies RA; Brennand JC; White A
Endocrinology; 2006 Apr; 147(4):1621-31. PubMed ID: 16384863
[TBL] [Abstract][Full Text] [Related]
3. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.
Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; Russell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR
Endocrinology; 1998 Oct; 139(10):4428-31. PubMed ID: 9751529
[TBL] [Abstract][Full Text] [Related]
4. Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways.
Preston E; Cooney GJ; Wilks D; Baran K; Zhang L; Kraegen EW; Sainsbury A
Neuropeptides; 2011 Dec; 45(6):407-15. PubMed ID: 21862125
[TBL] [Abstract][Full Text] [Related]
5. Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins.
Li YZ; Davidowa H
J Neurosci Res; 2004 Aug; 77(4):596-602. PubMed ID: 15264229
[TBL] [Abstract][Full Text] [Related]
6. The agouti-related protein and its role in energy homeostasis.
Stütz AM; Morrison CD; Argyropoulos G
Peptides; 2005 Oct; 26(10):1771-81. PubMed ID: 15961186
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
8. Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure.
Small CJ; Liu YL; Stanley SA; Connoley IP; Kennedy A; Stock MJ; Bloom SR
Int J Obes Relat Metab Disord; 2003 Apr; 27(4):530-3. PubMed ID: 12664087
[TBL] [Abstract][Full Text] [Related]
9. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
10. Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats.
Polidori C; Geary N; Massi M
Peptides; 2006 Jan; 27(1):144-9. PubMed ID: 16198024
[TBL] [Abstract][Full Text] [Related]
11. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
Joppa MA; Gogas KR; Foster AC; Markison S
Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
[TBL] [Abstract][Full Text] [Related]
12. Immediate and prolonged patterns of Agouti-related peptide-(83--132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites.
Hagan MM; Benoit SC; Rushing PA; Pritchard LM; Woods SC; Seeley RJ
Endocrinology; 2001 Mar; 142(3):1050-6. PubMed ID: 11181518
[TBL] [Abstract][Full Text] [Related]
13. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
14. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice.
Tolle V; Low MJ
Diabetes; 2008 Jan; 57(1):86-94. PubMed ID: 17909095
[TBL] [Abstract][Full Text] [Related]
15. Changes of agouti-related protein in hypothalamus, placenta, and serum during pregnancy in the rat.
Szczepankiewicz D; Pruszyńska-Oszmałek E; Kaczmarek P; Skrzypski M; Andrałojć K; Wojciechowicz T; Sassek M; Nowak KW
J Endocrinol; 2009 Jul; 202(1):35-41. PubMed ID: 19403567
[TBL] [Abstract][Full Text] [Related]
16. Altered neuronal responses to feeding-relevant peptides as sign of developmental plasticity in the hypothalamic regulatory system of body weight.
Davidowa H; Li Y; Plagemann A
Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(5):663-70. PubMed ID: 14658333
[TBL] [Abstract][Full Text] [Related]
17. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
19. Altered hypothalamic signaling and responses to food deprivation in rats fed a low-carbohydrate diet.
Kinzig KP; Scott KA; Hyun J; Bi S; Moran TH
Obes Res; 2005 Oct; 13(10):1672-82. PubMed ID: 16286514
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals.
Small CJ; Kim MS; Stanley SA; Mitchell JR; Murphy K; Morgan DG; Ghatei MA; Bloom SR
Diabetes; 2001 Feb; 50(2):248-54. PubMed ID: 11272133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
